<code id='92CBBB124E'></code><style id='92CBBB124E'></style>
    • <acronym id='92CBBB124E'></acronym>
      <center id='92CBBB124E'><center id='92CBBB124E'><tfoot id='92CBBB124E'></tfoot></center><abbr id='92CBBB124E'><dir id='92CBBB124E'><tfoot id='92CBBB124E'></tfoot><noframes id='92CBBB124E'>

    • <optgroup id='92CBBB124E'><strike id='92CBBB124E'><sup id='92CBBB124E'></sup></strike><code id='92CBBB124E'></code></optgroup>
        1. <b id='92CBBB124E'><label id='92CBBB124E'><select id='92CBBB124E'><dt id='92CBBB124E'><span id='92CBBB124E'></span></dt></select></label></b><u id='92CBBB124E'></u>
          <i id='92CBBB124E'><strike id='92CBBB124E'><tt id='92CBBB124E'><pre id='92CBBB124E'></pre></tt></strike></i>

          entertainment

          entertainment

          author:hotspot    Page View:12493

          The Senate has set its eyes on regulating insurance plans for some of the most vulnerable patients in the U.S. — the 12.5 million people eligible for both Medicare and Medicaid.

          “They’re a complex group of people with a lot of chronic conditions — mental illness, frailty, disability,” said Jose Figueroa, an internal medicine physician and health policy expert at Brigham and Women’s Hospital. Over a third of these dual-eligible beneficiaries have less than a high school education, and about 90% make less than $20,000 per year.

          advertisement

          Just around 15% of beneficiaries are eligible for both Medicare and Medicaid, but they account for a third of these programs’ spending — around $440 billion — and still don’t receive better health care, Sen. Bill Cassidy (R-La.) pointed out in a JAMA viewpoint published earlier this month. “The root cause of worse outcomes despite spending more money is a lack of coordination of care,” Cassidy wrote.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          Wikipedia

          Activists slam private health insurers over coverage restrictions
          Activists slam private health insurers over coverage restrictions

          ProtestorsoutsideAmerica'sHealthInsurancePlansheadquarters.CourtesyPeople'sActionWASHINGTON—Hun

          read more
          Readout LOUD podcast: The Sarepta saga, decoding biotech hype
          Readout LOUD podcast: The Sarepta saga, decoding biotech hype

          Whenisafailurenotafailure?DoestheFDAhavespecialrulesforSareptaTherapeutics?Andhowdoyousay“brash”inFr

          read more
          The cancer drug shortage isn’t new — and neither are the solutions
          The cancer drug shortage isn’t new — and neither are the solutions

          PreparingachemotherapytreatmentatDukeCancerCenterinDurham,N.C.GerryBroome/APAyounggirl,maybe5or6year

          read more

          Device maker Teleflex to acquire urology company for $600M

          AdobeTeleflexannouncedplansonWednesdaytoacquirePaletteLifeSciences,themakerofaslateofgel-basedproduc